KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Shares Issued (2018 - 2025)

Adaptive Biotechnologies' Shares Issued history spans 8 years, with the latest figure at $3.8 million for Q4 2025.

  • For Q4 2025, Shares Issued rose 2875.59% year-over-year to $3.8 million; the TTM value through Dec 2025 reached $12.5 million, up 5096.68%, while the annual FY2025 figure was $12.5 million, 5096.68% up from the prior year.
  • Shares Issued for Q4 2025 was $3.8 million at Adaptive Biotechnologies, up from $1.7 million in the prior quarter.
  • Across five years, Shares Issued topped out at $14.2 million in Q1 2021 and bottomed at -$2.2 million in Q4 2023.
  • The 5-year median for Shares Issued is $1.5 million (2023), against an average of $2.4 million.
  • The largest annual shift saw Shares Issued plummeted 770.19% in 2023 before it surged 12288.64% in 2025.
  • A 5-year view of Shares Issued shows it stood at $3.3 million in 2021, then plummeted by 90.18% to $322000.0 in 2022, then crashed by 770.19% to -$2.2 million in 2023, then soared by 105.89% to $127000.0 in 2024, then soared by 2875.59% to $3.8 million in 2025.
  • Per Business Quant, the three most recent readings for ADPT's Shares Issued are $3.8 million (Q4 2025), $1.7 million (Q3 2025), and $1.6 million (Q2 2025).